Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M004079200 on September 14, 2000

J. Biol. Chem., Vol. 275, Issue 49, 38938-38943, December 8, 2000
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
275/49/38938    most recent
M004079200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chu, G.
Right arrow Articles by Kranias, E. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chu, G.
Right arrow Articles by Kranias, E. G.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

A Single Site (Ser16) Phosphorylation in Phospholamban Is Sufficient in Mediating Its Maximal Cardiac Responses to beta -Agonists*

Guoxiang Chu, James W. Lester, Karen B. Young, Wusheng Luo, Jing Zhai, and Evangelia G. KraniasDagger

From the Department of Pharmacology & Cell Biophysics, University of Cincinnati College of Medicine, Cincinnati, Ohio 45267-0575

Phospholamban (PLB) can be phosphorylated at Ser16 by cyclic AMP-dependent protein kinase and at Thr17 by Ca2+-calmodulin-dependent protein kinase during beta -agonist stimulation. A previous study indicated that mutation of S16A in PLB resulted in lack of Thr17 phosphorylation and attenuation of the beta -agonist stimulatory effects in perfused mouse hearts. To further delineate the functional interplay between dual-site PLB phosphorylation, we generated transgenic mice expressing the T17A mutant PLB in the cardiac compartment of the null background. Lines expressing similar levels of T17A mutant, S16A mutant, or wild-type PLB in the null background were characterized in parallel. Cardiac myocyte basal mechanics and Ca2+ kinetics were similar among the three groups. Isoproterenol stimulation was associated with phosphorylation of both Ser16 and Thr17 in wild-type PLB and Ser16 phosphorylation in T17A mutant PLB, whereas there was no detectable phosphorylation of S16A mutant PLB. Phosphorylation of Ser16 alone in T17A mutant PLB resulted in responses of the mechanical and Ca2+ kinetic parameters to isoproterenol similar to those in wild-type myocytes, which exhibited dual-site PLB phosphorylation. However, those parameters were significantly attenuated in the S16A mutant myocytes. Thus, Ser16 in PLB can be phosphorylated independently of Thr17 in vivo, and phosphorylation of Ser16 is sufficient for mediating the maximal cardiac responses to beta -adrenergic stimulation.


* This study was supported by the National Institutes of Health Grants HL26057, HL52318, HL07382, and P40RR12358.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Dagger To whom correspondence should be addressed: Dept. of Pharmacology & Cell Biophysics, University of Cincinnati College of Medicine, 231 Bethesda Ave., Cincinnati, OH 45267-0575. Tel.: 513-558-2377; Fax: 513-558-2269; E-mail: kraniaeg@email.uc.edu.


Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Lipid Res.Home page
T.-L. Hwang, Y.-C. Su, H.-L. Chang, Y.-L. Leu, P.-J. Chung, L.-M. Kuo, and Y.-J. Chang
Suppression of superoxide anion and elastase release by C18 unsaturated fatty acids in human neutrophils
J. Lipid Res., July 1, 2009; 50(7): 1395 - 1408.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
H. M. Nef, H. Mollmann, C. Troidl, S. Kostin, S. Voss, P. Hilpert, C. B. Behrens, A. Rolf, J. Rixe, M. Weber, et al.
Abnormalities in intracellular Ca2+ regulation contribute to the pathomechanism of Tako-Tsubo cardiomyopathy
Eur. Heart J., June 13, 2009; (2009) ehp240v1.
[Abstract] [Full Text] [PDF]


Home page
Phil Trans R Soc AHome page
J. T. Koivumaki, J. Takalo, T. Korhonen, P. Tavi, and M. Weckstrom
Modelling sarcoplasmic reticulum calcium ATPase and its regulation in cardiac myocytes
Phil Trans R Soc A, June 13, 2009; 367(1896): 2181 - 2202.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. H. Gao, T. Tang, T. Guo, A. Miyanohara, T. Yajima, K. Pestonjamasp, J. R. Feramisco, and H. K. Hammond
Adenylyl Cyclase Type VI Increases Akt Activity and Phospholamban Phosphorylation in Cardiac Myocytes
J. Biol. Chem., November 28, 2008; 283(48): 33527 - 33535.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Manni, J. H. Mauban, C. W. Ward, and M. Bond
Phosphorylation of the cAMP-dependent Protein Kinase (PKA) Regulatory Subunit Modulates PKA-AKAP Interaction, Substrate Phosphorylation, and Calcium Signaling in Cardiac Cells
J. Biol. Chem., August 29, 2008; 283(35): 24145 - 24154.
[Abstract] [Full Text] [PDF]


Home page
PhysiologyHome page
L. F. Couchonnal and M. E. Anderson
The Role of Calmodulin Kinase II in Myocardial Physiology and Disease
Physiology, June 1, 2008; 23(3): 151 - 159.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
G. Chen, X. Zhou, P. Nicolaou, P. Rodriguez, G. Song, B. Mitton, A. Pathak, A. Zachariah, G.-C. Fan, G. W. Dorn II, et al.
A human polymorphism of protein phosphatase-1 inhibitor-1 is associated with attenuated contractile response of cardiomyocytes to {beta}-adrenergic stimulation
FASEB J, June 1, 2008; 22(6): 1790 - 1796.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
H. Wang, M. J. Kohr, C. J. Traynham, D. G. Wheeler, P. M. L. Janssen, and M. T. Ziolo
Neuronal nitric oxide synthase signaling within cardiac myocytes targets phospholamban
Am J Physiol Cell Physiol, June 1, 2008; 294(6): C1566 - C1575.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
M. J. Kohr, H. Wang, D. G. Wheeler, M. Velayutham, J. L. Zweier, and M. T. Ziolo
Targeting of phospholamban by peroxynitrite decreases {beta}-adrenergic stimulation in cardiomyocytes
Cardiovasc Res, January 15, 2008; 77(2): 353 - 361.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Lecchi, C. J. Nelson, K. E. Allen, D. L. Swaney, K. L. Thompson, J. J. Coon, M. R. Sussman, and C. W. Slayman
Tandem Phosphorylation of Ser-911 and Thr-912 at the C Terminus of Yeast Plasma Membrane H+-ATPase Leads to Glucose-dependent Activation
J. Biol. Chem., December 7, 2007; 282(49): 35471 - 35481.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
O. Cohen, H. Kanana, R. Zoizner, C. Gross, U. Meiri, M. D. Stern, G. Gerstenblith, and M. Horowitz
Altered Ca2+ handling and myofilament desensitization underlie cardiomyocyte performance in normothermic and hyperthermic heat-acclimated rat hearts
J Appl Physiol, July 1, 2007; 103(1): 266 - 275.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
Y. Ji, W. Zhao, B. Li, J. Desantiago, E. Picht, M. A. Kaetzel, J. E. J. Schultz, E. G. Kranias, D. M. Bers, and J. R. Dedman
Targeted inhibition of sarcoplasmic reticulum CaMKII activity results in alterations of Ca2+ homeostasis and cardiac contractility
Am J Physiol Heart Circ Physiol, February 1, 2006; 290(2): H599 - H606.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
A. Mattiazzi, C. Mundina-Weilenmann, C. Guoxiang, L. Vittone, and E. Kranias
Role of phospholamban phosphorylation on Thr17 in cardiac physiological and pathological conditions
Cardiovasc Res, December 1, 2005; 68(3): 366 - 375.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
K. Yamamura, C. Steenbergen, and E. Murphy
Protein kinase C and preconditioning: role of the sarcoplasmic reticulum
Am J Physiol Heart Circ Physiol, December 1, 2005; 289(6): H2484 - H2490.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
U. Kirchhefer, H. A. Baba, P. Boknik, K. M. Breeden, N. Mavila, N. Bruchert, I. Justus, M. Matus, W. Schmitz, A. A. DePaoli-Roach, et al.
Enhanced cardiac function in mice overexpressing protein phosphatase Inhibitor-2
Cardiovasc Res, October 1, 2005; 68(1): 98 - 108.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
F. U. Muller, G. Lewin, H. A. Baba, P. Boknik, L. Fabritz, U. Kirchhefer, P. Kirchhof, K. Loser, M. Matus, J. Neumann, et al.
Heart-directed Expression of a Human Cardiac Isoform of cAMP-Response Element Modulator in Transgenic Mice
J. Biol. Chem., February 25, 2005; 280(8): 6906 - 6914.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
G.-C. Fan, K. N. Gregory, W. Zhao, W. J. Park, and E. G. Kranias
Regulation of myocardial function by histidine-rich, calcium-binding protein
Am J Physiol Heart Circ Physiol, October 1, 2004; 287(4): H1705 - H1711.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
A. M Janczewski, M. Zahid, B. H Lemster, C. S Frye, G. Gibson, Y. Higuchi, E. G Kranias, A. M Feldman, and C. F McTiernan
Phospholamban gene ablation improves calcium transients but not cardiac function in a heart failure model
Cardiovasc Res, June 1, 2004; 62(3): 468 - 480.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Biol.Home page
A. Llach, J. Huang, F. Sederat, L. Tort, G. Tibbits, and L. Hove-Madsen
Effect of {beta}-adrenergic stimulation on the relationship between membrane potential, intracellular [Ca2+] and sarcoplasmic reticulum Ca2+ uptake in rainbow trout atrial myocytes
J. Exp. Biol., March 15, 2004; 207(8): 1369 - 1377.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
G. Chu, G. F. Egnaczyk, W. Zhao, S.-H. Jo, G.-C. Fan, J. E. Maggio, R.-P. Xiao, and E. G. Kranias
Phosphoproteome Analysis of Cardiomyocytes Subjected to {beta}-Adrenergic Stimulation: Identification and Characterization of a Cardiac Heat Shock Protein p20
Circ. Res., February 6, 2004; 94(2): 184 - 193.
[Abstract] [Full Text] [PDF]


Home page
Recent Prog Horm ResHome page
T. Zhang, S. Miyamoto, and J. H. Brown
Cardiomyocyte Calcium and Calcium/Calmodulin-dependent Protein Kinase II: Friends or Foes?
Recent Prog. Horm. Res., January 1, 2004; 59(1): 141 - 168.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
M. Said, L. Vittone, C. Mundina-Weilenmann, P. Ferrero, E. G. Kranias, and A. Mattiazzi
Role of dual-site phospholamban phosphorylation in the stunned heart: insights from phospholamban site-specific mutants
Am J Physiol Heart Circ Physiol, August 7, 2003; 285(3): H1198 - H1205.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
O. J. Muller, M. Lange, H. Rattunde, H.-P. Lorenzen, M. Muller, N. Frey, C. Bittner, W. Simonides, H. A. Katus, and W.-M. Franz
Transgenic rat hearts overexpressing SERCA2a show improved contractility under baseline conditions and pressure overload
Cardiovasc Res, August 1, 2003; 59(2): 380 - 389.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Ji, B. Li, T. D. Reed, J. N. Lorenz, M. A. Kaetzel, and J. R. Dedman
Targeted Inhibition of Ca2+/Calmodulin-dependent Protein Kinase II in Cardiac Longitudinal Sarcoplasmic Reticulum Results in Decreased Phospholamban Phosphorylation at Threonine 17
J. Biol. Chem., June 27, 2003; 278(27): 25063 - 25071.
[Abstract] [Full Text] [PDF]


Home page
Sci SignalHome page
R. H. G. Schwinger and K. F. Frank
Calcium and the Failing Heart: Phospholamban, Good Guy or Bad Guy?
Sci. Signal., April 29, 2003; 2003(180): pe15 - pe15.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
A. G. Brittsan, K. S. Ginsburg, G. Chu, A. Yatani, B. M. Wolska, A. G. Schmidt, M. Asahi, D. H. MacLennan, D. M. Bers, and E. G. Kranias
Chronic SR Ca2+-ATPase Inhibition Causes Adaptive Changes in Cellular Ca2+ Transport
Circ. Res., April 18, 2003; 92(7): 769 - 776.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
R. Dash, A. G Schmidt, A. Pathak, M. J Gerst, D. Biniakiewicz, V. J Kadambi, B. D Hoit, W. T Abraham, and E. G Kranias
Differential regulation of p38 mitogen-activated protein kinase mediates gender-dependent catecholamine-induced hypertrophy
Cardiovasc Res, March 1, 2003; 57(3): 704 - 714.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
T. ISODA, N. PAOLOCCI, K. HAGHIGHI, C. WANG, Y. WANG, D. GEORGAKOPOULOS, G. SERVILLO, M. A. DELLA FAZIA, E. G. KRANIAS, A. A. DEPAOLI-ROACH, et al.
Novel regulation of cardiac force-frequency relation by CREM (cAMP response element modulator)
FASEB J, February 1, 2003; 17(2): 144 - 151.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
F. del Monte and R. J Hajjar
Targeting calcium cycling proteins in heart failure through gene transfer
J. Physiol., January 1, 2003; 546(1): 49 - 61.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
K. F Frank, B. Bolck, E. Erdmann, and R. H.G Schwinger
Sarcoplasmic reticulum Ca2+-ATPase modulates cardiac contraction and relaxation
Cardiovasc Res, January 1, 2003; 57(1): 20 - 27.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
W. Zhao, K. F Frank, G. Chu, M. J Gerst, A. G Schmidt, Y. Ji, M. Periasamy, and E. G Kranias
Combined phospholamban ablation and SERCA1a overexpression result in a new hyperdynamic cardiac state
Cardiovasc Res, January 1, 2003; 57(1): 71 - 81.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
S. Huke, V. Prasad, M. L. Nieman, K. J. Nattamai, I. L. Grupp, J. N. Lorenz, and M. Periasamy
Altered dose response to beta -agonists in SERCA1a-expressing hearts ex vivo and in vivo
Am J Physiol Heart Circ Physiol, September 1, 2002; 283(3): H958 - H965.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
A. N. Carr, A. G. Schmidt, Y. Suzuki, F. del Monte, Y. Sato, C. Lanner, K. Breeden, S.-L. Jing, P. B. Allen, P. Greengard, et al.
Type 1 Phosphatase, a Negative Regulator of Cardiac Function
Mol. Cell. Biol., June 15, 2002; 22(12): 4124 - 4135.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
N.-O. Ku, S. Michie, E. Z. Resurreccion, R. L. Broome, and M. B. Omary
Keratin binding to 14-3-3 proteins modulates keratin filaments and hepatocyte mitotic progression
PNAS, April 2, 2002; 99(7): 4373 - 4378.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
Y. Kimura and M. Inui
Reconstitution of the Cytoplasmic Interaction between Phospholamban and Ca2+-ATPase of Cardiac Sarcoplasmic Reticulum
Mol. Pharmacol., March 1, 2002; 61(3): 667 - 673.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
N.-O. Ku, S. Michie, E. Z. Resurreccion, R. L. Broome, and M. B. Omary
Keratin binding to 14-3-3 proteins modulates keratin filaments and hepatocyte mitotic progression
PNAS, April 2, 2002; 99(7): 4373 - 4378.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2000 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement